stars 1 stars 2 stars 3

AI-First Pharmatech Company, a game-changer in AI-driven drug developing process. We discover, design and develop the drug by sequence-based end-to-end AI solution. - By integrating advanced AI technology and experts experience, Deargen is committed to discovering, designing and developing the best possible drugs in the fastest and most effective way. - Deargen specializes in discovering the Hit/Lead compound regardless of the target protein’s 3D information by first applying transformer technology into the pharmaceutical field. - Deargen members are experts in drug development, deep learning, software, biology, computational & medicinal chemistry, etc., for target discovery to lead optimization. Our end-to-end solution of AI platform allows saving time and cost compared to the traditional methods of drug discovery and development. - Deargen assures you that we can meet your unmet scientific needs by providing technology and experiences to develop new drugs.

Deargen Questions

Gilsu Kang is the CEO of Deargen.

12 people are employed at Deargen.

Top Deargen Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users